FDA.reportPublic FDA data

Xospata (as gilteritinib fumarate 44.2 MG) 40 MG Oral Tablet

RxCUI
2105817
RxNorm name
Xospata (as gilteritinib fumarate 44.2 MG) 40 MG Oral Tablet
Display name
Xospata (as gilteritinib fumarate 44.2 MG) 40 MG Oral Tablet
Full name
Xospata (as gilteritinib fumarate 44.2 MG) 40 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b5ff59aa-9c0d-49a8-9053-1f179b482383XOSPATA 40 MG Oral Tablet [PSN] · gilteritinib 40 MG Oral Tablet [Xospata] [SBD] · Xospata (as gilteritinib fumarate 44.2 MG) 40 MG Oral Tablet [SY]310These highlights do not include all the information needed to use XOSPATA safely and effectively. See full prescribing information for XOSPATA. XOSPATA ® (gilteritinib) tablets, for oral use Initial U.S. Approval: 201820220101